Research across Hepatitis B
Related studies from across the Hepatitis B family.
HBeAg positivity and high HBV DNA levels increase postpartum ALT elevation risk in chronic hepatitis B
Risk Factors for Liver Inflammation in Mothers with Hepatitis B
This meta-analysis of cohort studies identifies key risk factors for postpartum alanine aminotransferase (ALT) elevation in women with chron…
Specific factors like HBeAg positivity and high viral DNA levels can increase the risk of liver inflammation in women with chronic hepatitis…
HBsAg prevalence 7.0% in dialysis patients, with low HBV-DNA and suboptimal vaccination
Hepatitis B infection rates among patients on dialysis
This meta-analysis of 79 articles estimates hepatitis B burden in dialysis patients globally. Pooled HBsAg prevalence was 7.0% (95% CI 6.1-8…
New data shows that about 7% of patients on dialysis have Hepatitis B, highlighting the need for safer procedures and better vaccination rat…
Tonsillar metastasis in hepatocellular carcinoma patients may present as undifferentiated carcinoma with specific IHC markers
Lenvatinib and Chemoembolization Treatment Linked to Liver Cancer Metastasis
This case report and literature review describes a single patient with hepatocellular carcinoma and chronic hepatitis B presenting with a to…
A rare case of liver cancer spreading to the tonsils highlights the need for careful monitoring of head and neck symptoms in patients with l…
Direct-acting antiviral therapy and diverse viral infections require comprehensive epidemiological and diagnostic strategy review
Review Outlines Treatment and Prevention for Various Viral Infections
This systematic review covers the molecular biology, epidemiology, and treatment strategies for various viral infections including Hepatitis…
A comprehensive review outlines the biological traits, diagnosis methods, and treatment strategies for several common viral infections inclu…
Global HBsAg prevalence 3.2% in nurses, with 5.6% in Africa and 3.6% in LMICs
Nurses Face Higher Hepatitis B Risk in Poorer Countries
This meta-analysis estimates global hepatitis B surface antigen (HBsAg) prevalence among hospital-based nurses at 3.2% (95% CI 2.3-4.4), wit…
A global analysis finds 3.2% of hospital nurses carry hepatitis B, with rates four times higher in poorer countries.
Peg-interferon add-on to nucleoside analogues achieves HBsAg loss in 8.6% of patients
Adding peg-interferon to standard treatment helps some hepatitis B patients
This meta-analysis of 581 patients with chronic hepatitis B evaluates peg-interferon add-on to nucleoside analogue therapy. The analysis fou…
Adding peg-interferon to standard nucleoside therapy can help some patients with chronic hepatitis B achieve a key milestone in their treatm…
Viral hepatitis infections pose significantly higher risk for liver cancer than smoking-related lung cancer
Comparing the risks of liver cancer from hepatitis versus lung cancer from smoking
This meta-analysis of 86,097,714 participants analyzed the relative risks of liver cancer from various exposures compared to lung cancer fro…
New data shows that certain hepatitis viruses pose a much higher risk for liver cancer than smoking does for lung cancer.
HBsAg prevalence 9.98% in Cameroon, higher-risk groups 12.70%
New data reveals high rates of Hepatitis B in Cameroon
This meta-analysis of 100 studies estimates HBsAg prevalence at 9.98% in Cameroon, with lower-risk populations at 8.94% and higher-risk at 1…
Nearly 10 percent of people in Cameroon test positive for Hepatitis B, with higher rates found in certain high-risk groups.
Immune markers correlate with clinical outcomes following nucleos(t)ide analogue withdrawal in chronic hepatitis B
Immune Markers May Predict Outcomes After Hepatitis B Treatment
This mini review synthesizes immune correlates of outcome after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B. Bene…
New research identifies specific immune markers that may help predict how patients respond when stopping nucleoside analogue medications for…
Bidirectional virus-metabolism interaction in chronic hepatitis B and metabolic dysfunction-associated fatty liver disease
Liver disease and hepatitis B may fuel each other
This systematic review examines the interplay between viral infection and metabolic factors in patients with chronic hepatitis B and metabol…
Hepatitis B and fatty liver disease may worsen each other, raising liver cancer risk. New review explains the link.
Elevated serum M2BPGi is associated with a 4.61 hazard ratio for hepatocellular carcinoma development
Elevated M2BPGi Levels Linked to Higher Risk of Liver Cancer
This systematic review and meta-analysis of 12,161 participants found that elevated serum M2BPGi is significantly associated with an increas…
A large review of over 12,000 patients found that high levels of a specific protein may signal an increased risk for liver cancer.
Dolutegravir and lamivudine achieved 78% HIV-1 RNA suppression in patients with isolated reactive anti-HBc
Trial shows dolutegravir and lamivudine are safe for patients with HIV
This pooled analysis of Phase 3/3b trials evaluated dolutegravir/lamivudine (DTG/3TC) in adults with HIV-1 and isolated reactive hepatitis B…
A review of multiple trials shows that a common two-drug regimen effectively manages HIV while remaining safe for those with hepatitis B ant…